New endoscopy method may spot stomach cancer earlier
NCT ID NCT02738294
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a special endoscopy technique called ME-NBI (magnifying endoscopy with narrow band imaging) can better diagnose early stomach cancer than the standard white light biopsy. Researchers looked at 211 patients with suspicious stomach lesions. They compared the accuracy of ME-NBI targeted biopsy against standard forceps biopsy, using final surgical specimens as the gold standard.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ME-NBI (magnifying endoscopy with narrow band imaging) device
What this could lead to
If successful, this could show that ME-NBI targeted biopsy is more accurate than standard white light biopsy for diagnosing early gastric cancer, potentially reducing unnecessary biopsies.
What could go wrong
This is a completed study with 211 participants, so results are available but may not apply to all patients or settings. The technique requires specialized equipment and training.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY GASTRIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Departments of Gastroenterology and Clinical Laboratory, Shanghai Renji Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, 200001, China